Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519699 | SCV000617188 | uncertain significance | not provided | 2019-02-25 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016; McVean et al., 2012; Exome Variant Server); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge; Not located in the triple helical region, where the majority of pathogenic missense variants occur |
Labcorp Genetics |
RCV002231205 | SCV000945965 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2023-04-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350147 | SCV002643250 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2020-06-17 | criteria provided, single submitter | clinical testing | The p.P1780H variant (also known as c.5339C>A), located in coding exon 65 of the COL5A1 gene, results from a C to A substitution at nucleotide position 5339. The proline at codon 1780 is replaced by histidine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002497010 | SCV002778731 | uncertain significance | Ehlers-Danlos syndrome, classic type, 1; Fibromuscular dysplasia, multifocal | 2021-10-29 | criteria provided, single submitter | clinical testing |